← Evidence map

ArticleNature2026

Biomarkers of nivolumab benefit in resectable non-small cell lung cancer.

Tina Cascone et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 42587156